F. Michael Ball — CEO, Alcon at Novartis | Comparably
Thomas Glanzmann - Director at Alcon | The Org
Alcon CEO And Leadership: Executives and Demographics - Zippia
Untitled
Alcon - Governance - Board of Directors
Alcon CEO And Leadership: Executives and Demographics - Zippia
An Investment Review of Alcon Inc. Since Its Spin-off from Novartis
Michael Francis Land. 12 April 1942—14 December 2020 | Biographical Memoirs of Fellows of the Royal Society
Michael Onuscheck Net Worth (2023) | wallmine
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
F. Michael Ball News & Articles | Crain's Chicago Business
Meet Our Board - Ophthalmology Foundation
Alcon's top executive is out as eye-care sales plummet | Fort Worth Star-Telegram
Meet Our Board - Ophthalmology Foundation
Novartis sees weak Q4 and year, and expects a 2017 repeat, putting Alcon's future in question | Fierce Pharma
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
Alcon - Governance - Board of Directors
Alcon CEO And Leadership: Executives and Demographics - Zippia
Spotlight On... Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale; AZ sells rights to constipation drug; Denmark vies for EMA; and more...
Alcon becomes a separately traded standalone company | Novartis
F. Michael Ball News & Articles | Crain's Chicago Business
Alcon - Governance - Board of Directors
Alcon Laboratories India Private Limited - Board of Directors
Alcon - Governance - Board of Directors
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
Alcon - Governance - Board of Directors
2021 Annual Report Wrapper
